Skip to main navigation

Mobile navigation

Contact Us Portals

Tests

Tests Tests

Tests for Providers

Tests for Providers

Afirma
Genomic Sequencing Classifier Decipher
Prostate Genomic Classifier Decipher
Bladder Genomic Classifier

Prosigna
Breast Risk of Recurrence Test TrueMRD
Monitoring Test for MIBC

Discover

Provider Resource Center Scientific Publications Veracyte Diagnostics Platform Clinical Studies

Connect With Us

Ordering Portal Contact Us

Tests for Patients

Cancer Tests

Afirma
Thyroid Nodule Test Decipher
Prostate Cancer Test Decipher
Bladder Cancer Test

Prosigna
Breast Cancer Test TrueMRD
Monitoring Test for MIBC

Learn

Patient Resource Center Patient Video Stories Frequently Asked Questions

Need Help?

Payment Portal Contact Us

Resources

Resources

Resources For Providers

Resources Centers

Decipher
Prostate Resources Decipher
Bladder Resources Afirma
Thyroid Resources Prosigna
Breast Resources TrueMRD
MIBC Resources View All →

Explore

Scientific Publications Frequently Asked Questions Video Gallery Document Library Cancer Diagnostic Labs

Connect With Us

Ordering Portal Contact Us

Resources For Patients

Resource Centers

Decipher
Prostate Resources Decipher
Bladder Resources Afirma
Thyroid Resources Prosigna
Breast Resources View All →

Explore

Patient Video Stories Frequently Asked Questions

Connect With Us

Payment Portal Contact Us

Innovation

Technology

Veracyte Diagnostics Platform Clinical Studies Technology & Pipeline

TrueMRD Platform Cancer Diagnostic Labs

Research use only

Afirma GRID Decipher GRID

Innovation Innovation

column Technology

column

column Research use only

Company

About Us

About Veracyte Leadership Careers Working at Veracyte Frequently Asked Questions

News & Events

Events & Webinars Press Releases In the News Blog

Connect

Contact Us

Company Company

column About Us

column News & Events

column Connect

Investors

Welcome

Overview Press Releases Events & Presentations

Financials

SEC Filings Quarterly Results Annual Reports Proxy Statements Stock Information Analyst Coverage

Governance

Governance Overview Leadership Committee Composition ESG Information

Investor Resources

Investor FAQs Information Request Email Alerts

Investors Investors

column Welcome

column Financials

column Governance

column Investor Resources

Patient Payment Portal
Provider Portal

Tests

Tests for Providers
Afirma
Genomic Sequencing Classifier Decipher
Prostate Genomic Classifier Decipher
Bladder Genomic Classifier

Prosigna
Breast Risk of Recurrence Test TrueMRD
Monitoring Test for MIBC

Discover
Provider Resource Center Scientific Publications Veracyte Diagnostics Platform Clinical Studies

Connect With Us
Ordering Portal Contact Us

Cancer Tests
Afirma
Thyroid Nodule Test Decipher
Prostate Cancer Test Decipher
Bladder Cancer Test

Prosigna
Breast Cancer Test TrueMRD
Monitoring Test for MIBC

Learn
Patient Resource Center Patient Video Stories Frequently Asked Questions

Need Help?
Payment Portal Contact Us
Resources

Resources Centers
Decipher
Prostate Resources Decipher
Bladder Resources Afirma
Thyroid Resources Prosigna
Breast Resources TrueMRD
MIBC Resources View All →

Explore
Scientific Publications Frequently Asked Questions Video Gallery Document Library Cancer Diagnostic Labs

Connect With Us
Ordering Portal Contact Us

Resource Centers
Decipher
Prostate Resources Decipher
Bladder Resources Afirma
Thyroid Resources Prosigna
Breast Resources View All →

Explore
Patient Video Stories Frequently Asked Questions

Connect With Us
Payment Portal Contact Us
Innovation

Technology
Veracyte Diagnostics Platform Clinical Studies Technology & Pipeline

TrueMRD Platform Cancer Diagnostic Labs

Research use only
Afirma GRID Decipher GRID
Company

About Us
About Veracyte Leadership Careers Working at Veracyte Frequently Asked Questions

News & Events
Events & Webinars Press Releases In the News Blog

Connect
Contact Us
Investors

Welcome
Overview Press Releases Events & Presentations

Financials
SEC Filings Quarterly Results Annual Reports Proxy Statements Stock Information Analyst Coverage

Governance
Governance Overview Leadership Committee Composition ESG Information

Investor Resources
Investor FAQs Information Request Email Alerts

Press Releases

Items Per Page

Year

Jul 30, 2026

Veracyte Announces Second Quarter 2026 Financial Results

Read More

Jul 28, 2026

Veracyte to Participate in Upcoming Investor Conferences

Read More

Jul 09, 2026

Veracyte to Release Second Quarter 2026 Financial Results on July 30, 2026

Read More

Jun 01, 2026

Veracyte Announces Commercial Launch of the Prosigna Breast Test in the U.S.

Read More

May 30, 2026

ENZAMET Trial Shows Veracyte's Decipher Prostate Test Identifies Which Patients Benefit from Adding Chemotherapy in Metastatic Prostate Cancer

Read More

May 29, 2026

Landmark OPTIMA Trial Delivers Practice-Changing Evidence that Veracyte’s Prosigna Test Identifies Patients with High-Risk Breast Cancer Who Can Safely Avoid Chemotherapy

Read More

May 22, 2026

Veracyte to Host Investor Call on June 1, 2026 to Discuss ASCO Findings

Read More

May 21, 2026

OPTIMA Trial Results to Be Presented at ASCO Provide New Evidence Supporting Prosigna-Guided Chemotherapy Decisions in Breast Cancer

Read More

May 19, 2026

Veracyte to Participate in Upcoming Investor Conferences

Read More

May 15, 2026

Veracyte Secures Medicare Coverage for TrueMRD Monitoring Test in Muscle-Invasive Bladder Cancer

Read More

Pagination

Current page 1
Page 2
Page 3
…
Next page
Last page

Displaying 1 - 10 of 562

Contact Investor Relations

Please feel free to contact us if you have questions or would like additional investor relations information:

investors@veracyte.com
+1 619.393.1545

Shareholder Tools

menu_book Printed Materials
print Print
share Share

Subscribe to Investor Alerts

Sign up

Menu - Footer - Mobile Buttons

Contact Us Portals

6000 Shoreline Court, Suite 300
San Francisco, CA 94080

+1-650-243-6335

Contact Us

Connect:

Afirma
Genomic Sequencing Classifier
Decipher
Bladder Genomic Classifier
Decipher
Prostate Genomic Classifier
Prosigna
Breast Risk of Recurrence Test
TrueMRD
Monitoring Test for MIBC

Veracyte Diagnostics
Platform
Clinical Studies
Technology & Pipeline
Scientific Publications
Resource Center
Document Library
Portals

In the News
Press Releases
Events & Webinars

About Veracyte
Leadership
Careers
Investors
Frequently Asked Questions
Blog
Corporate Recognition

© 2026 Veracyte, Inc. All rights reserved.

Instructions for Use
Safety Data Sheets
Privacy Notice
Accessibility

Terms of Use
Terms of Sale
No Surprises Act
Ethics & Compliance
Licenses & Certificates
Trademarks
Site Map

This website contains information on products which is targeted to a wide range of audiences and could contain product details or information otherwise not accessible or valid in your country. Please be aware that we do not take any responsibility for accessing such information which may not comply with any legal process, regulation, registration or usage in the country of your origin.

Facebook
Twitter
LinkedIn